For the third consecutive year, Greenburgh-based pharmaceutical company Regeneron has been recognized by Science magazine as the No. 1 biopharmaceutical employer in the world in the publication”™s Top Employer”™s Survey.
“Regeneron’s success can be directly attributed to our incredible, dedicated employees who have an unparalleled commitment to turning science into medicines that will help people with serious diseases,” said Leonard S. Schleifer, Regeneron Pharmaceuticals Inc. president and CEO, in a statement. “Our unique culture nurtures and rewards innovation in R&D and throughout the company.”
The 2014 Science survey sought to identify the companies with the best reputations as employers, based on 5,394 survey responses from readers of Science and other survey invitees. Seventy percent of survey participants came from North America, while 23 percent came from Europe and 6 percent from Asia and the Pacific Rim. Ninety-one percent of the respondents work in biotechnology, biopharmaceutical and pharmaceutical companies.
“As our company grows, we remain relentless in our focus on advancing cutting-edge scientific innovation and achievement,” said George D. Yancopoulos, chief scientific officer of Regeneron and president of Regeneron Laboratories. “Every one of our nearly 3,000 employees knows that he or she has an important impact on advancing meaningful work that will help patients.”
According to a Regeneron press release, the award indicates that the company earned high marks among survey respondents for being an innovative leader in industry, treating employees with respect, engendering employee loyalty, operating in a manner that is socially responsible, having clear vision and producing important, quality research.
